cheqfx
Advertisement · 728×90
‹ All stocks
NPCE

NeuroPace

NPCE · NASDAQ · Healthcare
$12.94
▼ $12.94 (-3.02%)
$12.94 $13.31 $13.67 $14.04 $12.94 Sep 26 Sep 30 Oct 04
Day range
$12.93 – $13.34
Year range
$9.22 – $19.60
Open
$13.34
Previous close
—
Market cap
$441.08M
Volume (24h)
$43.3K
Volume (52w)
$559.63K
Performance
7D
▼ -8.57%
1M
▼ -14.83%
3M
▼ -25.35%
6M
▼ -11.39%
1Y
▲ 24.04%
YTD
▼ -14.72%
3Y
▲ 53.83%
5Y
▼ -24.70%
All-time
▼ -48.17%
Key statistics
P/E ratio
-22.70
EPS (TTM)
$-0.57
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
34.1M
About NeuroPace

NeuroPace, Inc. is a U.S.-based medical technology firm. It specializes in the creation and distribution of the RNS system, an advanced brain-responsive neuromodulation device designed to manage medically intractable focal epilepsy. This innovative system delivers tailored, real-time therapy directly to the source of seizures. Furthermore, the RNS system continuously records brain activity, providing medical professionals with the capability to monitor patients both on-site and remotely. The company supplies its devices to hospitals for both initial surgical implantations and subsequent replacement procedures. NeuroPace, Inc. was founded in 1997 and maintains its corporate headquarters in Mountain View, California.

Visit website
Country: United States of America
More in Healthcare